background
middl
east
respiratori
syndrom
coronaviru
infect
associ
high
mortal
rate
limit
clinic
data
report
describ
clinic
featur
outcom
patient
admit
intens
care
unit
icu
middl
east
respiratori
syndrom
coronaviru
merscov
infect
method
retrospect
analysi
data
adult
year
old
patient
admit
mix
icu
middl
east
respiratori
syndrom
coronaviru
infect
octob
may
diagnosi
confirm
patient
use
realtim
revers
transcript
polymeras
chain
reaction
respiratori
sampl
result
observ
period
patient
admit
merscov
infect
mean
age
year
male
cough
tachypnea
report
patient
patient
bilater
pulmonari
infiltr
invas
mechan
ventil
appli
vasopressor
therapi
patient
intens
care
unit
stay
twentythre
patient
die
icu
nonsurvivor
older
greater
apach
ii
sofa
score
admiss
like
receiv
invas
mechan
ventil
vasopressor
therapi
adjust
sever
ill
degre
organ
dysfunct
need
vasopressor
independ
risk
factor
death
icu
odd
ratio
confid
interv
p
conclus
merscov
infect
requir
admiss
icu
associ
high
morbid
mortal
need
vasopressor
therapi
main
risk
factor
death
patient
middl
east
respiratori
syndrom
coronaviru
merscov
novel
betacoronaviru
first
report
septemb
januari
total
laboratoryconfirm
case
infect
merscov
includ
least
relat
death
report
world
health
organ
although
merscov
infect
report
countri
around
world
major
case
origin
saudi
arabia
south
korea
unit
arab
emir
jordan
qatar
interhuman
merscov
transmiss
occur
commun
healthcar
set
exact
sourc
mode
transmiss
merscov
human
remain
uncertain
howev
merscov
circul
among
dromedari
camel
africa
middl
east
occas
document
camelhuman
intertransmiss
sever
report
outlin
clinic
featur
outcom
patient
merscov
infect
howev
focus
critic
ill
patient
intens
care
unit
icu
therefor
need
data
understand
variou
clinic
prognost
aspect
potenti
lethal
diseas
particularli
sever
case
requir
admiss
icu
perform
retrospect
studi
describ
clinic
featur
outcom
patient
admit
icu
laboratoryconfirm
merscov
infect
studi
approv
institut
review
board
princ
sultan
militari
medic
citi
riyadh
saudi
arabia
larg
tertiarycar
referr
center
riyadh
saudi
arabia
inform
consent
waiv
due
retrospect
anonym
natur
data
collect
includ
patient
age
year
confirm
merscov
infect
admit
mix
medicosurg
icu
octob
may
icu
patient
confirm
diagnosi
merscov
regist
special
logbook
purpos
current
studi
patient
record
review
senior
intensivist
hussain
alwan
abudayah
altayyar
mustafa
aldaghestani
alghamedi
talag
malik
clinic
data
laboratori
paramet
confirm
case
merscov
transcrib
onto
special
develop
case
record
form
includ
initi
manifest
respiratori
infect
clinic
pictur
admiss
icu
laboratori
indic
organ
failur
radiograph
find
intervent
icu
stay
treatment
modal
final
outcom
acut
physiolog
chronic
health
evalu
ii
apach
ii
score
calcul
data
obtain
within
hour
admiss
icu
sequenti
organ
failur
assess
sofa
score
calcul
daili
physician
charg
patient
also
note
sinc
first
report
case
merscov
saudi
arabia
septemb
suspect
case
institut
strictli
isol
nasopharyng
swab
obtain
initi
screen
deep
respiratori
sampl
tracheal
aspir
bronchoalveolar
lavag
fluid
obtain
patient
admit
icu
suspect
respiratori
infect
addit
blood
sampl
perform
cultur
polymeras
chain
reaction
common
respiratori
virus
atyp
microorgan
urinari
sampl
obtain
detect
legionella
antigen
two
patient
legionella
infect
common
saudi
patient
cultur
tracheal
aspir
analyz
quantit
bacteri
count
least
colonyform
unit
consid
posit
investig
repeat
icu
whenev
secondari
infect
suspect
clinic
specimen
aim
detect
possibl
merscov
infect
process
analyz
nation
refer
laboratori
saudi
ministri
health
merscov
infect
identifi
use
realtim
revers
transcript
polymeras
chain
reaction
rtpcr
standard
assay
target
amplif
upstream
e
protein
upe
gene
open
read
frame
orf
need
posit
confirm
infect
otherwis
anoth
sampl
requir
confirm
diagnosi
sampl
requir
day
process
final
result
avail
routin
laboratori
test
icu
includ
complet
blood
count
coagul
profil
electrolyt
renal
function
liver
profil
arteri
blood
gase
paramet
measur
admiss
icu
least
daili
thereaft
throughout
icu
stay
patient
suspect
confirm
merscov
infect
isol
singl
room
either
hospit
floor
icu
patient
admit
icu
accord
guidelin
societi
critic
care
medicin
icu
admiss
discharg
triag
patient
classifi
four
categori
accord
icu
admiss
prioriti
prioriti
one
compris
critic
ill
patient
unstabl
need
intens
treatment
monitor
signific
likelihood
recoveri
prioriti
two
stabl
patient
requir
intens
monitor
possibl
decompens
prioriti
three
unstabl
patient
low
likelihood
recoveri
sever
acut
diseas
comorbid
prioriti
four
littl
anticip
benefit
icu
admiss
patient
classifi
prioriti
one
two
classifi
prioriti
three
admit
icu
full
critic
care
servic
mobil
provid
isol
ward
bed
avail
icu
prioriti
four
patient
admit
icu
remain
isol
ward
gener
ward
patient
merscov
infect
transfer
icu
condit
deterior
organ
failur
develop
infect
control
precaut
recommend
saudi
ministri
health
guidelin
strictli
implement
prevent
possibl
transmiss
merscov
patient
healthcar
staff
support
treatment
provid
accord
standard
oper
procedur
accord
surviv
sepsi
campaign
guidelin
antivir
therapi
oseltamivir
ribavirininterferon
prescrib
discret
attend
physician
protect
lung
ventil
appli
mechan
ventil
patient
prone
posit
consid
patient
sever
refractori
hypoxemia
extracorpor
membran
oxygen
ecmo
highfrequ
oscil
also
avail
last
resort
consid
necessari
attend
physician
statist
analys
perform
use
spss
statist
window
ibm
corp
armonk
ny
usa
kolmogorovsmirnov
test
use
verifi
whether
signific
deviat
normal
assumpt
continu
variabl
nonparametr
test
comparison
use
variabl
evalu
normal
distribut
differ
test
group
perform
use
student
test
mannwhitney
test
chisquar
test
fisher
exact
test
appropri
friedman
test
use
assess
time
cours
organ
function
identifi
risk
factor
death
icu
perform
multivari
logist
regress
analys
due
rel
small
number
death
studi
adjust
sever
ill
admiss
icu
apach
ii
score
degre
organ
dysfunct
assess
admiss
sofa
score
potenti
risk
factor
icu
mortal
select
among
demograph
characterist
comorbid
mode
acquisit
merscov
initi
manifest
procedur
therapi
superimpos
infect
variabl
yield
p
univari
analysi
apach
ii
score
sofa
score
includ
multivari
logist
regress
analysi
variabl
introduc
separ
multivari
model
includ
apach
ii
sofa
score
admiss
icu
adjust
odd
ratio
confid
interv
ci
comput
none
covari
simultan
introduc
multivari
model
collinear
data
present
mean
standard
deviat
sd
median
valu
interquartil
rang
iqr
number
appropri
statist
twotail
p
consid
statist
signific
observ
period
case
confirm
merscov
infect
diagnos
institut
fig
patient
manag
hospit
ward
patient
admit
icu
receiv
critic
care
servic
ward
patient
admit
icu
octob
decemb
januari
may
patient
admit
icu
respiratori
failur
mmhg
mean
age
patient
admit
icu
n
sd
year
male
characterist
patient
admiss
icu
shown
tabl
eighteen
patient
communityacquir
merscov
infect
includ
two
healthcar
staff
infect
acquir
hospit
twentyseven
patient
least
one
comorbid
median
number
concomit
comorbid
condit
three
iqr
initi
clinic
manifest
occur
median
day
iqr
prior
hospit
admiss
patient
treat
median
day
iqr
gener
hospit
ward
admiss
icu
four
patient
admit
icu
arriv
hospit
cough
tachypnea
report
patient
common
initi
symptom
fever
abdomin
pain
sore
throat
fatigu
addit
file
crackl
tachycardia
rhonchi
commonli
identifi
initi
physic
sign
bilater
pulmonari
infiltr
present
chest
xray
patient
lobar
infiltr
six
one
patient
normal
chest
xray
time
admiss
icu
admiss
icu
patient
microbiolog
proven
coexist
bacteri
pneumonia
secondari
infect
evid
posit
quantit
cultur
deep
tracheal
aspir
occur
patient
within
median
day
iqr
admiss
icu
commonli
isol
microorgan
acinetobact
baumannii
four
patient
posit
blood
cultur
acinetobact
baumannii
n
escherichia
coli
n
methicillinresist
staphylococcu
aureu
n
vancomycinresist
enterococcu
speci
n
invas
mechan
ventil
appli
patient
icu
stay
within
hour
admiss
icu
patient
receiv
noninvas
ventil
tabl
eleven
patient
treat
highfrequ
oscil
five
prone
posit
one
patient
receiv
ecmo
ventilatori
paramet
present
addit
file
vasopressor
therapi
use
norepinephrin
initi
patient
tabl
oseltamivir
administ
patient
median
day
iqr
combin
ribavirin
plu
interferon
therapi
use
patient
tabl
patient
receiv
least
one
antimicrobi
agent
icu
stay
addit
file
antifung
therapi
use
four
five
patient
posit
cultur
candida
necess
therapi
uncertain
overal
icu
mortal
rate
n
median
icu
hospit
length
stay
iqr
iqr
day
respect
major
caus
death
hypoxem
respiratori
failur
refractori
septic
shock
one
patient
die
sudden
cardiac
arrest
icu
discharg
still
hospit
furthermor
one
patient
die
within
year
discharg
icu
septic
shock
relat
infect
wound
one
patient
lost
followup
hospit
discharg
sofa
score
glasgow
coma
scale
gc
increas
markedli
first
week
icu
whole
cohort
paramet
organ
function
remain
larg
unchang
addit
file
compar
discharg
aliv
icu
nonsurvivor
older
higher
apach
ii
sofa
score
admiss
icu
like
requir
invas
mechan
ventil
vasopressor
therapi
ventil
use
highfrequ
oscil
tabl
addit
file
nonsurvivor
persist
low
throughout
first
week
icu
wherea
survivor
show
slight
increas
time
fig
adjust
sever
ill
degre
organ
dysfunct
need
vasopressor
independ
risk
factor
death
icu
confid
interv
p
addit
file
critic
ill
patient
confirm
merscov
infect
cohort
frequent
organ
failur
overal
mortal
rate
greater
comorbid
common
cohort
patient
surprisingli
mortal
icu
associ
older
age
sever
diseas
organ
failur
need
vasopressor
therapi
independ
risk
factor
death
icu
sinc
first
report
case
merscov
infect
sever
author
describ
variou
cohort
patient
seriou
infect
facil
larg
tertiarycar
medic
center
riyadh
central
saudi
arabia
herein
provid
detail
account
largest
singl
cohort
critic
ill
merscov
infect
patient
report
thu
far
agreement
previou
report
saudi
arabia
comorbid
condit
common
patient
merscov
infect
median
three
comorbid
per
patient
contrast
individu
involv
recent
merscov
outbreak
south
korea
preexist
chronic
medic
condit
howev
patient
korean
outbreak
age
year
older
nearli
half
caregiv
healthcar
personnel
differ
demograph
characterist
cohort
mode
acquisit
merscov
infect
may
explain
least
part
discrep
pattern
associ
comorbid
saudi
korean
cohort
respiratori
manifest
merscov
infect
cohort
similar
observ
previou
report
saudi
patient
cough
tachypnea
occur
patient
case
bilater
pulmonari
infiltr
denot
sever
respiratori
ill
requir
median
day
reach
peak
clinic
deterior
icu
admiss
organ
support
therapi
requir
gastrointestin
manifest
abdomin
pain
diarrhea
vomit
abdomin
tender
rel
common
cohort
also
common
find
previou
literatur
patient
merscov
infect
well
sever
acut
respiratori
syndrom
sar
data
confirm
previou
studi
report
high
preval
nonrespiratori
organ
failur
critic
ill
patient
merscov
mechan
organ
dysfunct
failur
patient
yet
determin
cytokin
dysregul
suggest
involv
pathophysiolog
merscovrel
organ
failur
direct
viral
invas
may
also
occur
viru
recov
urin
stool
one
patient
agreement
result
previou
report
critic
ill
patient
merscov
infect
patient
receiv
vasopressor
support
underscor
high
preval
cardiovascular
dysfunct
patient
suggest
disturb
tissu
perfus
may
also
involv
pathophysiolog
organ
failur
lower
rate
vasopressor
support
report
patient
sar
result
lower
mortal
rate
report
patient
merscov
infect
even
though
overal
mortal
rate
high
cohort
still
compar
rate
report
previou
studi
studi
almost
patient
signific
comorbid
median
apach
ii
score
higher
observ
significantli
higher
apach
ii
sofa
score
icu
nonsurvivor
compar
surviv
sever
merscov
infect
underscor
strong
associ
mortal
sever
diseas
epidemiolog
analys
suggest
merscov
unlik
trigger
sustain
human
epidem
present
nevertheless
nosocomi
outbreak
result
consider
morbid
mortal
addit
disrupt
medic
servic
substanti
econom
loss
sever
infect
usual
requir
icu
admiss
necessit
major
resourc
util
result
high
fatal
rate
identifi
possibl
risk
factor
poor
prognosi
patient
merscov
infect
therefor
crucial
enabl
appropri
alloc
healthcar
resourc
earli
transfer
highrisk
patient
appropri
medic
facil
data
show
need
vasopressor
therapi
independ
risk
factor
death
icu
inde
major
caus
death
studi
hypoxem
respiratori
failur
refractori
septic
shock
confirm
role
respiratori
cardiovascular
system
failur
determin
outcom
popul
also
evid
persist
hypoxemia
observ
nonsurvivor
date
publish
data
risk
factor
poor
prognosi
specif
critic
ill
patient
merscov
infect
lack
cohort
studi
patient
degre
sever
merscov
infect
older
age
diabet
chronic
renal
failur
chronic
respiratori
diseas
high
viral
load
lower
respiratori
tract
sampl
shorter
incub
period
merscov
viremia
identifi
independ
predictor
mortal
secondari
respiratori
infect
occur
commonli
cohort
predominantli
gramneg
bacteria
although
candida
speci
frequent
isol
probabl
relev
respiratori
pathogen
necess
antifung
therapi
uncertain
interestingli
acinetobact
baumannii
emerg
fatal
infect
icu
patient
worldwid
isol
deep
tracheal
aspir
one
four
patient
may
explain
least
part
rel
high
mortal
rate
cohort
specif
therapeut
option
mercov
infect
limit
efficaci
well
establish
patient
report
receiv
antivir
treatment
either
oseltamivir
combin
ribavirininterferon
therapi
two
patient
receiv
although
previou
studi
institut
show
combin
ribavirininterferon
therapi
associ
signific
improv
surviv
day
benefit
maintain
day
onset
diseas
retrospect
observ
natur
studi
allow
precis
assess
efficaci
therapi
absenc
vaccin
specif
treatment
prevent
viral
transmiss
adequ
infect
control
method
mainstay
manag
merscov
outbreak
appropri
isol
patient
suspect
proven
infect
crucial
view
high
fatal
rate
patient
icu
may
reason
close
monitor
patient
suspect
infect
gener
ward
earli
sign
organ
dysfunct
prevent
unnecessari
delay
provis
intens
care
servic
reduc
mortal
rate
patient
studi
limit
includ
patient
confirm
merscov
infect
one
icu
larg
medic
center
possibl
variat
geograph
distribut
diseas
local
practic
may
hinder
extrapol
data
cohort
saudi
arabia
countri
rel
low
number
patient
may
bias
statist
comparison
present
report
overestim
mortal
rate
multivari
adjust
also
limit
variabl
includ
model
collabor
effort
need
provid
insight
risk
factor
poor
prognosi
patient
